72 related articles for article (PubMed ID: 3122797)
1. Cost effectiveness of screening for only anti-HBc in institutions for mentally retarded persons.
Akhter MN; Van Tiunen M; Metzger R; Goins J
Am J Ment Retard; 1987 Nov; 92(3):279-81. PubMed ID: 3122797
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of prevaccination screening for hepatitis B antibody.
Jacobson JJ; La Turno DE; Johnston FK; Shipman C
J Dent Educ; 1987 Feb; 51(2):94-7. PubMed ID: 3100594
[TBL] [Abstract][Full Text] [Related]
3. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
Zhang SX
Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
[TBL] [Abstract][Full Text] [Related]
4. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
5. [A study on serologic markers for screening before hepatitis B vaccination].
Hui Z; Zhao Z; Zhang L
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):351-3. PubMed ID: 7874705
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of hepatitis B screening in a mental health institution.
Leonard J; Holtgrave DR; Johnson RP
J Fam Pract; 1991 Jan; 32(1):45-8. PubMed ID: 1824638
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of hepatitis B infections among residents of an institution for the mentally retarded in New Mexico.
Mann JM; Babb CJ; Hull HF; Ball FD; Brown GW; Steece RS
West J Med; 1984 Sep; 141(3):339-41. PubMed ID: 6506672
[TBL] [Abstract][Full Text] [Related]
8. [Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum].
Vrijmoeth P; Heijtink RA; Schreuder H; Kroes AC
Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1694-7. PubMed ID: 9543786
[TBL] [Abstract][Full Text] [Related]
9. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
[TBL] [Abstract][Full Text] [Related]
10. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
11. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.
Gandhi RT; Wurcel A; Lee H; McGovern B; Boczanowski M; Gerwin R; Corcoran CP; Szczepiorkowski Z; Toner S; Cohen DE; Sax PE; Ukomadu C
Clin Infect Dis; 2003 Jun; 36(12):1602-5. PubMed ID: 12802762
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccination and anti-HBc-positive livers in children.
Lacaille F
Hepatology; 2003 Nov; 38(5):1311; author reply 1312. PubMed ID: 14578873
[No Abstract] [Full Text] [Related]
13. [High percentage of isolated anti-HBc-positive persons among prisoners].
Neifer S; Molz B; Sucker U; Kreuzpaintner E; Weinberger K; Jilg W
Gesundheitswesen; 1997 Jun; 59(6):409-12. PubMed ID: 9333377
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
15. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
[TBL] [Abstract][Full Text] [Related]
16. Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centres.
Fisker N; Georgsen J; Stolborg T; Khalil MR; Christensen PB
J Med Virol; 2002 Dec; 68(4):500-4. PubMed ID: 12376957
[TBL] [Abstract][Full Text] [Related]
17. [Anti-HBc IgM antibodies: prevalence during HB virus infection and value of studying titers].
Pelletier G; Briantais MJ; Attali P; Buffet C; Pillot J
Gastroenterol Clin Biol; 1984; 8(8-9):651-5. PubMed ID: 6489685
[TBL] [Abstract][Full Text] [Related]
18. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
Ren F; Li H; Zhao H
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
[TBL] [Abstract][Full Text] [Related]
19. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
20. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant?
Mattern RM; Cavanagh HD
Cornea; 1997 Mar; 16(2):138-45. PubMed ID: 9071525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
